Roflumilast
Therapeutic Group
Drugs For Obstructive Airway Diseases, SystemicIndication Dosage
Adjunct To Bronchodilators Maintenance Treatment Of Severe Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis And A History Of Frequent Exacerbations:
- Adult: 500 Micrograms Once Daily
Content
- Tab 500mcg: Roflumilast 500mcg
Pregnancy
Caution Advised
Stability
- Phosphodiesterase Type-4 Inhibitors
Contra Indications
- Moderate To Severe Cardiac Failure, Moderate To Severe Hepatic Impairment, History Of Depression Associated With Suicidal Ideation Or Behavior, Severe Acute Infections, Cancer, Concomitant Treatment With Immunosuppressive Drugs, Severe Immunological Disease
Precautions
- Moderate To Severe Cardiac Failure, Moderate To Severe Hepatic Impairment, History Of Depression Associated With Suicidal Ideation Or Behavior, Severe Acute Infections, Cancer, Concomitant Treatment With Immunosuppressive Drugs, Severe Immunological Disease
Lactation
- Caution Advised
Side Effects
- Abdominal Pain
- Decreased Appetite
- Diarrhoea
- Headache
- Insomnia
- Nausea
- Weight Loss
- Anxiety
- Dizziness
- Dyspepsia
- Gastritis
- Gord
- Constipation
- Malaise
- Muscle Spasm
- Myalgia
- Palpitation
- Rash
- Tremor
- Vertigo .rare: Depression
- Gynaecomastia
- Haematochezia
- Nervousness
- Raised Creatine Kinase
- Respiratory Tract Infections
- Suicidal Behavior
- Suicidal Ideation
- Taste Disturbances
- Urticaria